Lester L Maravetz

This inventor holds 24 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Herbicide Development. Top assignees: Fmc Corporation, Reata Pharmaceuticals, Inc., Basf Se Corporation. Active years: 1977-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lester L Maravetz. Retrieved from https://idiyas.com/inventor/lester-l-maravetz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 91.7

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1

Average Co-Inventor Count = 1.6

ph-index = 6

Forward Citations = 170(Granted Patents)

Company Filing History:

Reata Pharmaceuticals, Inc.

Mobil Oil Corporation

patents

Years Active: 1977-2012

Loading Chart...

Areas of Expertise:

Herbicide

Oleanolic Acid

Benzofused Heterocycles

Pyrazolyl Compounds

Insecticide

Nitrogen-Containing Compounds

Triazolinones

Amino Compounds

Phenyl-Substituted

Heterocyclic

Inflammation Modulators

Derivatives

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8338618 - Antioxidant inflammation modulators: novel derivatives of oleanolic acid (2012-12-25),

2. 8071632 - Antioxidant inflammation modulators: novel derivatives of oleanolic acid (2011-12-06),

3. 7842832 - β-amino-α-cyanoacrylates and their use as herbicides (2010-11-30),

4. 6352958 - Cycloimido-substituted benzofused heterocyclic herbicides (2002-03-05),

5. H0001942 - Herbicidal 3-(pyrazolylphenyl)propanoic acids and derivatives (2001-02-06),

6. H001923 - Herbicidal (oxaalkyl) phenyl-substituted heterocycles (2000-11-06),

7. 6080702 - Herbicidal heterocyclic benzisoxazoles and benzisoxazolidinones (2000-06-27),

8. 6077812 - Cycloimido-substituted benzofused heterocyclic herbicides (2000-06-20),

9. H001759 - Herbicidal benzyloxyphenyl-substituted heterocycles (1998-11-02),

10. 5753595 - Herbicidal 3-(substituted benzoxazol-7-yl) and 3-(Substituted (1998-05-19),

11. 5661108 - Herbicidal 3-(bicyclic nitrogen-containing (1997-08-26),

12. 5321002 - Herbicidal derivatives of (1994-06-14),

13. 5262382 - Herbicidal 1-pyridylpyrazole compounds (1993-11-16),

14. 5250504 - Herbicidal .beta.-pyrazolylacrylic acids (1993-10-05),

15. 5198014 - Herbicidal beta-pyrazolylacrylic acid compound (1993-03-30),

Title: **Lester L. Maravetz: Innovator in Antioxidant Inflammation Modulators**

Introduction

Lester L. Maravetz is a distinguished inventor based in Westfield, NJ, known for his significant contributions to the field of biotechnology. With a remarkable portfolio of 24 patents, Maravetz has been at the forefront of innovation, focusing on developing novel compounds that address critical health challenges.

Latest Patents

Among his latest achievements are patents related to antioxidant inflammation modulators, specifically novel derivatives of oleanolic acid. These compounds have been carefully designed to offer methods of preparation and applications that may aid in the treatment and prevention of various diseases, including cancer, neurological disorders, and conditions involving oxidative stress and inflammation. The potential therapeutic impact of these derivatives underscores Maravetz's commitment to advancing health solutions through innovative research.

Career Highlights

Throughout his career, Lester L. Maravetz has made notable contributions while working with impactful companies such as FMC Corporation and Reata Pharmaceuticals, Inc. His experience in these leading organizations has equipped him with the expertise necessary to drive forward his innovative projects and enhance their outcomes.

Collaborations

Maravetz has collaborated with esteemed professionals in the field, including George Theodoridis and Scott D. Crawford. These partnerships have not only enriched his work but have also fostered a collaborative spirit aimed at tackling complex health problems through innovative solutions.

Conclusion

Lester L. Maravetz continues to embody the spirit of innovation through his extensive patent portfolio and collaboration with leading figures in the biotechnology sector. His focus on developing effective treatments for serious health conditions showcases his dedication to enhancing public health through scientific advancements.

Profile summary based on public USPTO records.